List of Tables
Table 1. Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Homozygous Familial Hypercholesterolemia Treatment Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Homozygous Familial Hypercholesterolemia Treatment Covered in This Study
Table 5. Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Homozygous Familial Hypercholesterolemia Treatment Sales Share by Manufacturers (2016-2021)
Table 7. Global Homozygous Familial Hypercholesterolemia Treatment Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Homozygous Familial Hypercholesterolemia Treatment Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Homozygous Familial Hypercholesterolemia Treatment Manufacturing Sites and Area Served
Table 11. Manufacturers Homozygous Familial Hypercholesterolemia Treatment Product Type
Table 12. Global Homozygous Familial Hypercholesterolemia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Homozygous Familial Hypercholesterolemia Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Homozygous Familial Hypercholesterolemia Treatment as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Homozygous Familial Hypercholesterolemia Treatment Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Region (2016-2021)
Table 17. Global Homozygous Familial Hypercholesterolemia Treatment Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Homozygous Familial Hypercholesterolemia Treatment Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Country (2016-2021)
Table 20. North America Homozygous Familial Hypercholesterolemia Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Country (2016-2021)
Table 22. Europe Homozygous Familial Hypercholesterolemia Treatment Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Country (2016-2021)
Table 24. Europe Homozygous Familial Hypercholesterolemia Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Homozygous Familial Hypercholesterolemia Treatment Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Homozygous Familial Hypercholesterolemia Treatment Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Region (2016-2021)
Table 30. Latin America Homozygous Familial Hypercholesterolemia Treatment Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Country (2016-2021)
Table 32. Latin America Homozygous Familial Hypercholesterolemia Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Homozygous Familial Hypercholesterolemia Treatment Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Homozygous Familial Hypercholesterolemia Treatment Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Country (2016-2021)
Table 38. Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Type (2016-2021)
Table 39. Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Type (2016-2021)
Table 40. Global Homozygous Familial Hypercholesterolemia Treatment Revenue (Million US$) by Type (2016-2021)
Table 41. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Share by Type (2016-2021)
Table 42. Global Homozygous Familial Hypercholesterolemia Treatment Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs) by Application (2016-2021)
Table 44. Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Application (2016-2021)
Table 45. Global Homozygous Familial Hypercholesterolemia Treatment Revenue (Million US$) by Application (2016-2021)
Table 46. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Share by Application (2016-2021)
Table 47. Global Homozygous Familial Hypercholesterolemia Treatment Price (USD/Pcs) by Application (2016-2021)
Table 48. CymaBay Therapeutics Inc Corporation Information
Table 49. CymaBay Therapeutics Inc Description and Business Overview
Table 50. CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. CymaBay Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Product
Table 52. CymaBay Therapeutics Inc Recent Developments/Updates
Table 53. Daewoong Co Ltd Corporation Information
Table 54. Daewoong Co Ltd Description and Business Overview
Table 55. Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Daewoong Co Ltd Homozygous Familial Hypercholesterolemia Treatment Product
Table 57. Daewoong Co Ltd Recent Developments/Updates
Table 58. Gemphire Therapeutics Inc Corporation Information
Table 59. Gemphire Therapeutics Inc Description and Business Overview
Table 60. Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Gemphire Therapeutics Inc Homozygous Familial Hypercholesterolemia Treatment Product
Table 62. Gemphire Therapeutics Inc Recent Developments/Updates
Table 63. LipimetiX Development Inc Corporation Information
Table 64. LipimetiX Development Inc Description and Business Overview
Table 65. LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. LipimetiX Development Inc Homozygous Familial Hypercholesterolemia Treatment Product
Table 67. LipimetiX Development Inc Recent Developments/Updates
Table 68. Regeneron Pharmaceuticals Inc Corporation Information
Table 69. Regeneron Pharmaceuticals Inc Description and Business Overview
Table 70. Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Regeneron Pharmaceuticals Inc Homozygous Familial Hypercholesterolemia Treatment Product
Table 72. Regeneron Pharmaceuticals Inc Recent Developments/Updates
Table 73. RegenxBio Inc Corporation Information
Table 74. RegenxBio Inc Description and Business Overview
Table 75. RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. RegenxBio Inc Homozygous Familial Hypercholesterolemia Treatment Product
Table 77. RegenxBio Inc Recent Developments/Updates
Table 78. The Medicines Company Corporation Information
Table 79. The Medicines Company Description and Business Overview
Table 80. The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. The Medicines Company Homozygous Familial Hypercholesterolemia Treatment Product
Table 82. The Medicines Company Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Homozygous Familial Hypercholesterolemia Treatment Distributors List
Table 86. Homozygous Familial Hypercholesterolemia Treatment Customers List
Table 87. Homozygous Familial Hypercholesterolemia Treatment Market Trends
Table 88. Homozygous Familial Hypercholesterolemia Treatment Growth Drivers
Table 89. Homozygous Familial Hypercholesterolemia Treatment Market Restraints
Table 90. Global Homozygous Familial Hypercholesterolemia Treatment Sales Forecast by Type (2022-2027) & (K Pcs)
Table 91. Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share Forecast by Type (2022-2027)
Table 92. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 93. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share Forecast by Type (2022-2027)
Table 94. Global Homozygous Familial Hypercholesterolemia Treatment Sales Forecast by Application (2022-2027) & (K Pcs)
Table 95. Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share Forecast by Application (2022-2027)
Table 96. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 97. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share Forecast by Application (2022-2027)
Table 98. Global Homozygous Familial Hypercholesterolemia Treatment Sales Forecast by Region (2022-2027) & (K Pcs)
Table 99. Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share Forecast by Region (2022-2027)
Table 100. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 101. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share Forecast by Region (2022-2027)
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Homozygous Familial Hypercholesterolemia Treatment
Figure 2. Global Homozygous Familial Hypercholesterolemia Treatment Market Share by Type in 2020 & 2027
Figure 3. AEM-2802 Product Picture
Figure 4. AEM-2814 Product Picture
Figure 5. Alirocumab Product Picture
Figure 6. Evinacumab Product Picture
Figure 7. Others Product Picture
Figure 8. Global Homozygous Familial Hypercholesterolemia Treatment Market Share by Application in 2020 & 2027
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Global Homozygous Familial Hypercholesterolemia Treatment Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Homozygous Familial Hypercholesterolemia Treatment Market Size 2016-2027 (US$ Million)
Figure 14. Global Homozygous Familial Hypercholesterolemia Treatment Sales 2016-2027 (K Pcs)
Figure 15. Global Homozygous Familial Hypercholesterolemia Treatment Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Homozygous Familial Hypercholesterolemia Treatment Sales Share by Manufacturers in 2020
Figure 17. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Homozygous Familial Hypercholesterolemia Treatment Players: Market Share by Revenue in 2020
Figure 19. Homozygous Familial Hypercholesterolemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Region (2016-2021)
Figure 21. Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Share by Region in 2020
Figure 22. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Region (2016-2021)
Figure 23. Global Homozygous Familial Hypercholesterolemia Treatment Revenue Market Share by Region in 2020
Figure 24. U.S. Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Homozygous Familial Hypercholesterolemia Treatment Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Homozygous Familial Hypercholesterolemia Treatment by Type (2016-2021)
Figure 49. Sales Market Share of Homozygous Familial Hypercholesterolemia Treatment by Application (2016-2021)
Figure 50. Sales Market Share of Homozygous Familial Hypercholesterolemia Treatment by Application in 2020
Figure 51. Revenue Share of Homozygous Familial Hypercholesterolemia Treatment by Application (2016-2021)
Figure 52. Revenue Share of Homozygous Familial Hypercholesterolemia Treatment by Application in 2020
Figure 53. Manufacturing Cost Structure of Homozygous Familial Hypercholesterolemia Treatment
Figure 54. Manufacturing Process Analysis of Homozygous Familial Hypercholesterolemia Treatment
Figure 55. Homozygous Familial Hypercholesterolemia Treatment Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

LIST OF FIGURE